Hematology and Oncology
Home Hematology and Oncology
Fiber Tied to Lower Mortality in Those With Colorectal Cancer
Increasing fiber consumption after diagnosis may lower risk of all-cause, CRC-specific mortality
Pricing Interventions Increase Sales, Intake of Healthy Foods
Also linked to reduced purchasing and consumption of unhealthy foods and beverages
Almost One in Four Skin Biopsies Is Melanocytic Proliferation
83.1 percent classified as nevi, other benign proliferations such as mildly dysplastic lesions
Driving Impairment Warnings Often Not Given With Rx Meds
For most drug categories, those who do receive warnings perceive higher risk of impaired driving
Liposuction Can Reduce Lymphedema-Related Swelling
Case report describes beneficial effect for three patients with lymphedema affecting the leg or arm
PARP Inhibitors Promising Beyond BRCA1/2 Altered Tumors
Talazoparib caused regression in 5 patient-derived xenografts, 4 without germline BRCA1/2 mutations
October 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2017. This roundup includes...
Response to Lenalidomide Often Suboptimal in MDS/MPN-RS-T
Hematological responses seen in three patients with MDS/MPN-RS-T, but the responses not durable
Hepatitis B Viral Load, Surface Antigen May ID Liver Cancer Risk
Increased risk of liver cancer linked to hepatitis B DNA, surface antigen in a dose-response manner
CMS Launches Initiative to Examine Impact of Regulations
Officials set to travel country gathering information on impact of their regulations on physicians
